Yuki SETOGUCHI, Akiko HAYASHI, Ayami KAWADA, Ayako IBUSUKI, Daigo YANAOKA, Ryota SAITO, Tomoko ISHIBASHI, Hiroaki TAKIMOTO, Yoshihide YAMAGUCHI, Hirokazu OHTAKI, et al. Intravenous immunoglobulin preparations attenuate lysolecithin-induced peripheral demyelination in mice and comprise anti-large myelin protein zero antibody. Proceedings of the Japan Academy, Series B. 2023. 99. 2. 48-60
Yoshinori Otani, Akihiro Taguchi, Keisuke Hamada, Yoshio Hayashi, Yoshihide Yamaguchi, Hiroko Baba. Influence of novel readthrough agents on myelin protein zero translation in the peripheral nervous system. Neuropharmacology. 2022. 109059-109059
Yoshinori Otani, Nobuhiko Ohno, Jingjing Cui, Yoshihide Yamaguchi, Hiroko Baba. Upregulation of large myelin protein zero leads to Charcot-Marie-Tooth disease-like neuropathy in mice. Communications biology. 2020. 3. 1. 121-121
R. Yamazaki, Y. Yamaguchi, T. Ishibashi, H. Baba. Unconventional myosin id is involved in the remyelination process after cuprizone-induced demyelination. JOURNAL OF NEUROCHEMISTRY. 2017. 142. 172-173
YAMAZAKI Reiji, YAMAGUCHI Yoshihide, ISHIBASHI Tomoko, BABA Hiroko. Unconventional myosin ID has an important role in oligodendrocyte during remyelination. 日本神経化学会大会抄録集(Web). 2017. 60th
R. Yamazaki, Y. Yamaguchi, T. Ishibashi, H. Baba. Analysis of myosin superfamily in mature cultured oligodendrocytes and in cuprizone-treated de- and remyelination model mice. JOURNAL OF NEUROCHEMISTRY. 2015. 134. 109-109